Precision brain health. To help prevent, diagnose and personalize treatment for brain disorders.
Joined April 2018
- Tweets 427
- Following 712
- Followers 227
- Likes 1,605
73 Photos and videos
Pinned Tweet
23 Jan 2023
Thanks Fox Business for featuring a short film, that will air nationally at about ViewMind Inc.#healthcare #technology #neurology #neuroscience #neurology #alzheimersdisease #MultipleSclerosis #biomarkers #neurodegenerativediseases #neurologicaldisorders #endalz
4
619
26 Sep 2025
š ViewMind has graduated from the AgeTech Collaborativeā¢ from AARP Accelerator Program!
Weāre proud to be an AgeTech Collaborativeā¢ Portfolio Company advancing innovation in cognitive health and longevity.
#agetech #AgeTechCollaborative #longevity #neurotech #digitalhealth
32
5 Aug 2025
Thank you to everyone who visited our stand and experienced ViewMindās technology firsthand at the @alzassociation ās International Conference in Toronto.
linkedin.com/feed/update/urnā¦
#AAIC2025 #BrainHealth #Alzheimers #ClinicalTrials #DigitalBiomarkers #Innovation
1
18
29 Jul 2025
Weāve just presented one of our new studies at AAIC 2025: āCognitive and Motor Behaviors in Alzheimerās, Parkinsonās, and Healthy Individuals.ā
Visit us at Booth #1437 to learn more about our cutting-edge cognitive assessment platform.
#AAIC2025
@alzassociation
23
27 Jul 2025
We are here at AAIC 2025
š Booth #1437 | 27 to 29 July 2025 | Toronto, Canada
Weāre proud to be presenting cutting-edge research and showcasing our patented cognitive assessment platform, ViewMind Atlasā¢.
@alzassociation #AAIC2025 #BrainHealth #Alzheimers #HealthTech
2
27
27 Jul 2025
Weāre presenting 3 scientific posters, including:
ā¢ Psychometric validation of ViewMind Atlasā¢ as a digital biomarker
ā¢ Comparison with traditional neuropsychological tests
ā¢ Cognitive & motor patterns in AD, Parkinsonās, and healthy individuals
21
27 Jul 2025
ViewMind Atlasā¢ is a non-invasive, eye-tracking-based digital tool that has the potential to support:
ā Early detection of Alzheimerās
ā Cognitive endpoints in clinical trials
ā Scalable integration into research and healthcare environments
19
31 Jan 2025
ALZHEIMERāS DRUG DISCOVERY FOUNDATIONāS DIAGNOSTICS ACCELERATOR (DXA) Invests $1.4M in ViewMindās technology. einpresswire.com/article/780ā¦ via @ein_news
#BrainHealth #Alzheimers #NeurologicalDisorders #HealthTech #EyeTracking #InnovationInHealthcare #Biomarkers #PrecisionMedicine
1
37
23 Dec 2024
As the year comes to a close, we want to take a moment to express our gratitude to our partners and supporters. Together, we advanced our mission of transforming brain health through innovative, data-driven solutions.
#BrainHealth #HealthInnovation #CognitiveHealth #ThankYou
1
1
45
23 Dec 2024
We look forward to continued collaboration in 2025 as we keep pushing the boundaries of cognitive health assessments.
Thank you for being part of our journey.
Wishing you all a peaceful holiday season and a successful new year.
21
17 Dec 2024
We are pleased to share that Dr. Danilo Verge, @ViewMind_ 's Chief Medical Officer, presented to nearly 300 endocrinologists at the Intensive @cursodavidson 2024 in Miami.
#ViewMind #MedicalEducation #CognitiveHealth #Endocrinology #DiagnosticsInnovation
1
31
17 Dec 2024
ViewMindās non-invasive technology offers valuable insights that have the potential to also be relevant for endocrinologists. By detecting cognitive changes in cardiometabolic conditions, our solution has the potential to support earlier intervention and personalized care.
1
24
17 Dec 2024
We appreciate the opportunity to contribute to discussions that drive innovation in brain health diagnostics.
19
10 Dec 2024
ViewMind is proud to announce its participation in the Bio-Hermes-002 study in collaboration with the Global Alzheimerās Platform FoundationĀ® (GAP).
#BioHermes002 #AlzheimersResearch #DiversityInResearch #DigitalBiomarkers #ViewMind #Cognitive
1
1
88
10 Dec 2024
"In addition, ViewMind has developed a specialized assessment for Alzheimerās disease. Initial results indicate high sensitivity and specificity to detect asymptomatic stages over 10 years before symptoms and amnestic MCI. ā said Mark Edwards, CEO & Co-founder of ViewMind Inc.
1
27
10 Dec 2024
"This advancement holds the potential to make a significant impact on healthcare. We are excited to participate in the landmark Bio-Hermes-002 study to validate our results,ā said Mark Edwards, CEO & Co-founder of ViewMind Inc.
31
26 Nov 2024
We are honored to announce that ViewMind Inc. has been named one of the three winners of the Accelerate UK 2024 competition!
We are thrilled to be joining the #AccelerateUK program and look forward to the opportunities it will bring.
#innovation #BrainHealth #Health #healthcare
2
1
3
675
26 Nov 2024
A huge thank you to the #AccelerateUK team for this opportunity, and congratulations to all finalists
2
28
26 Nov 2024
Being selected as a winner underscores the global crisis in brain and mental health, highlighting the urgent need for solutions like ViewMindās, which offers precise, rapid, scalable, and affordable brain health assessments.
1
34